Juan Cristobal Morales Muñoz/LinkedIn
Oct 10, 2026, 10:40
Juan Cristóbal Morales Muñoz: Pharmacokinetic Profiling of Factor VIII Concentrates in Chilean Patients
Juan Cristóbal Morales Muñoz, Adjunct Instructor at Pontifical Catholic University of Chile, shared a post on LinkedIn:
“The abstract of our work presented at ISTH 2026 has been published in RPTH Journal
In this series, recombinant factor VIII showed a longer half-life than plasma-derived factor VIII, although there were important differences between patients.
In patients with severe haemophilia A treated at Hospital Sótero del Río in Santiago, Chile, these findings support individual pharmacokinetic assessment with WAPPS-Hemo, particularly after switching concentrates, to better adjust doses and dosing intervals.
This work was conducted with Antonio Ibarra Quezada, Magaly Cruces Ortiz, and José Luis Lamas.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 10:32Randall Schaefer: When Your Prehospital Agency Reports Blood Product Wastage Rates, What is it Really Reporting?
-
Oct 10, 2026, 10:26Simone Strasser: ROTEM-Guided Transfusion Cuts Blood Product Use in Patients with Cirrhosis
-
Oct 10, 2026, 10:18Jérôme S.: WHO Launches Global Roadmap to Combat Hypertensive Disorders of Pregnancy
-
Oct 10, 2026, 10:07Maha Othman: Look Forward to an Amazing ISTH 2027 in Vancouver!
-
Oct 10, 2026, 10:02Rucha Patil: National Convening Highlights Opportunities for Equitable Hemophilia Care Across India
-
Oct 10, 2026, 09:52Yuria Ito: Should Ferritin Testing Become a Routine Part of Prenatal Care in Japan?
-
Oct 10, 2026, 09:48Ahmed Alotaibi: Can We “Remove” the ABO Problem from Group O Platelets?
-
Oct 10, 2026, 09:31Help Shape the New ASH Iron Deficiency Guidelines – American Society of Hematology
-
Oct 10, 2026, 09:05Wolfgang Miesbach: Moving from Bleed Control to Comprehensive Joint Health